173 related articles for article (PubMed ID: 32997547)
1. Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy.
Verdonschot JAJ; Merken JJ; van Stipdonk AMW; Pliger P; Derks KWJ; Wang P; Henkens MTHM; van Paassen P; Abdul Hamid MA; van Empel VPM; Knackstedt C; Luermans JGLM; Crijns HJGM; Brunner-La Rocca HP; Brunner HG; Poelzl G; Vernooy K; Heymans SRB; Hazebroek MR
Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008727. PubMed ID: 32997547
[TBL] [Abstract][Full Text] [Related]
2. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
[TBL] [Abstract][Full Text] [Related]
3. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
[TBL] [Abstract][Full Text] [Related]
4. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Patients With Cardiac Sarcoidosis Who Received Cardiac Resynchronization Therapy: Comparison With Dilated Cardiomyopathy Patients.
Yufu K; Kondo H; Shinohara T; Kawano K; Ishii Y; Miyoshi M; Imamura T; Saito S; Okada N; Akioka H; Teshima Y; Nakagawa M; Takahashi N
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):177-181. PubMed ID: 27862596
[TBL] [Abstract][Full Text] [Related]
6. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
Risum N
Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.
Hasselberg NE; Haugaa KH; Bernard A; Ribe MP; Kongsgaard E; Donal E; Edvardsen T
Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):343-50. PubMed ID: 26164406
[TBL] [Abstract][Full Text] [Related]
8. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
Martinelli Filho M; de Lima Peixoto G; de Siqueira SF; Martins SAM; Nishioka SAD; Pedrosa AAA; Teixeira RA; Dos Santos JX; Costa R; Kalil Filho R; Ramires JAF
Europace; 2018 Nov; 20(11):1813-1818. PubMed ID: 29509903
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.
Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372
[TBL] [Abstract][Full Text] [Related]
10. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
[TBL] [Abstract][Full Text] [Related]
11. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
[TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.
Bilchick K; Kothari H; Narayan A; Garmey J; Omar A; Capaldo B; McNamara C
Cardiovasc Res; 2020 Jun; 116(7):1311-1322. PubMed ID: 31612215
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
[TBL] [Abstract][Full Text] [Related]
14. Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation.
Stolfo D; Tonet E; Barbati G; Gigli M; Pinamonti B; Zecchin M; Ramani F; Merlo M; Sinagra G
Pacing Clin Electrophysiol; 2015 Nov; 38(11):1287-96. PubMed ID: 26256433
[TBL] [Abstract][Full Text] [Related]
15. [Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy].
Vaĭkhanskaia TG; Kurushko TV; Sidorenko IV; Koptiukh TM; Gul' LM; Mel'nikova OP; Golenishcha VF; Kovalenko ON
Kardiologiia; 2013; 53(3):48-54. PubMed ID: 23548427
[TBL] [Abstract][Full Text] [Related]
16. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
[TBL] [Abstract][Full Text] [Related]
18. Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration.
Mischke K; Knackstedt C; Fache K; Reith S; Rana O; Saygili E; Gemein C; Becker M; Marx N; Schauerte P
Acta Cardiol; 2011 Apr; 66(2):175-80. PubMed ID: 21591575
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
[TBL] [Abstract][Full Text] [Related]
20. Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
Zavadovsky KV; Gulya MO; Lishmanov YB; Lebedev DI
Ann Nucl Med; 2016 Jun; 30(5):325-33. PubMed ID: 26872805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
